A Chinese firm holding the majority stake of PatientsLikeMe, an online network for information, support and study recruitment for chronic conditions, is facing pressure from a US federal committee to sell its shares of the company due to concerns of foreign investment and influence, according to a CNBC report citing anonymous insiders.
iCarbonX, a health data and genomics company founded by...
